Atlas Trials

Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy

Clinical trial NCT00777179 · COMPLETED

Trial details

NCT number
NCT00777179
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2008-10-01
Primary completion
2010-01-01
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.